Targeted Antimicrobial Agents as Potential Tools for Modulating the Gut Microbiome

被引:11
|
作者
Chou, Shuli [1 ]
Zhang, Shiqing [1 ]
Guo, Huating [1 ]
Chang, Yung-fu [2 ]
Zhao, Wenjing [1 ]
Mou, Xiangyu [1 ,3 ]
机构
[1] Shenzhen Campus Sun Yat Sen Univ, Ctr Infect & Immun Studies, Sch Med, Shenzhen, Peoples R China
[2] Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY USA
[3] Sun Yat Sen Univ, Affiliated Hosp 6, Guangdong Prov Key Lab Colorectal & Pelv Floor Dis, Guangzhou, Peoples R China
基金
中国国家自然科学基金;
关键词
berberine; polyphenols; bacteriocins; antimicrobial peptides; phage therapy; targeted drug delivery system; pathobionts; microbiome editing; FUSOBACTERIUM-NUCLEATUM; ANTI-MRSA; BACTERIOCIN; PEPTIDE; ASSOCIATIONS; MECHANISM; DATABASE; PLANT; PH;
D O I
10.3389/fmicb.2022.879207
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The gut microbiome plays a pivotal role in maintaining the health of the hosts; however, there is accumulating evidence that certain bacteria in the host, termed pathobionts, play roles in the progression of diseases. Although antibiotics can be used to eradicate unwanted bacteria, the side effects of antibiotic treatment lead to a great need for more targeted antimicrobial agents as tools to modulate the microbiome more precisely. Herein, we reviewed narrow-spectrum antibiotics naturally made by plants and microorganisms, followed by more targeted antibiotic agents including synthetic peptides, phage, and targeted drug delivery systems, from the perspective of using them as potential tools for modulating the gut microbiome for favorable effects on the health of the host. Given the emerging discoveries on pathobionts and the increasing knowledge on targeted antimicrobial agents reviewed in this article, we anticipate targeted antimicrobial agents will emerge as a new generation of a drug to treat microbiome-involved diseases.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] The Gut Microbiome, Kidney Disease, and Targeted Interventions
    Ramezani, Ali
    Raj, Dominic S.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2014, 25 (04): : 657 - 670
  • [22] Targeted Approaches for In Situ Gut Microbiome Manipulation
    Lee, Hui Ling
    Shen, Haosheng
    Hwang, In Young
    Ling, Hua
    Yew, Wen Shan
    Lee, Yung Seng
    Chang, Matthew Wook
    GENES, 2018, 9 (07):
  • [23] Targeted Approaches for In Situ Gut Microbiome Manipulation
    Cresci, Gail A. M.
    Lampe, Johanna W.
    Gibson, Glenn
    JOURNAL OF PARENTERAL AND ENTERAL NUTRITION, 2020, 44 (04) : 581 - 588
  • [24] The Role of Chronic Pain in Modulating Preterm Infants' Gut Microbiome
    Xu, Wanli
    Cong, Xiaomei
    Henderson, Wendy
    NURSING RESEARCH, 2017, 66 (02) : E106 - E107
  • [25] The role of the gut microbiome in modulating immunotherapy efficacy in colorectal cancer
    Zuo, Siyuan
    Huang, Yong
    Zou, Junwei
    IUBMB LIFE, 2024, 76 (12) : 1050 - 1057
  • [26] Targeted prebiotics alter the obese gut microbiome in humans
    Junjun She
    Chi Chun Wong
    Jun Yu
    Signal Transduction and Targeted Therapy, 6
  • [27] Targeted prebiotics alter the obese gut microbiome in humans
    She, Junyun
    Wong, Chi Chun
    Yu, Jun
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2021, 6 (01)
  • [28] Rethinking antimicrobial stewardship paradigms in the context of the gut microbiome
    Shahi, Farah
    Redeker, Kelly
    Chong, James
    JAC-ANTIMICROBIAL RESISTANCE, 2019, 1 (01):
  • [29] Antimicrobial peptides and the gut microbiome in inflammatory bowel disease
    Gubatan, John
    Holman, Derek R.
    Puntasecca, Christopher J.
    Polevoi, Danielle
    Rubin, Samuel J. S.
    Rogalla, Stephan
    WORLD JOURNAL OF GASTROENTEROLOGY, 2021, 27 (43) : 7402 - 7422
  • [30] Antimicrobial peptides and the gut microbiome in inflammatory bowel disease
    John Gubatan
    Derek R Holman
    Christopher J Puntasecca
    Danielle Polevoi
    Samuel JS Rubin
    Stephan Rogalla
    World Journal of Gastroenterology, 2021, 27 (43) : 7402 - 7422